Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Thirty-year outcomes of the national hepatitis B immunization program in Taiwan.

Literature DB >> 24002285

Thirty-year outcomes of the national hepatitis B immunization program in Taiwan.

Chun-Ju Chiang¹, Ya-Wen Yang, San-Lin You, Mei-Shu Lai, Chien-Jen Chen.

Abstract

Entities: Disease

Mesh：

Substances：
Hepatitis B Vaccines

Year: 2013 PMID： 24002285 DOI： 10.1001/jama.2013.276701

Source DB: PubMed Journal: JAMA ISSN： 0098-7484 Impact factor: 56.272

Keyword Cloud
Cited

× No keyword cloud information.

59 in total

1. Cost-effectiveness of augmenting universal hepatitis B vaccination with immunoglobulin treatment: a case study in Zhejiang Province, East China.

Authors: Yanbing Zeng; Mingliang Luo; Jianlin Lin; Hanqing He; Xuan Deng; Shuyun Xie; Ya Fang
Journal: Hum Vaccin Immunother Date: 2019-11-26 Impact factor: 3.452

2. Vaccines: taking a shot at protection.

Authors: Karen Weintraub
Journal: Nature Date: 2014-12-04 Impact factor: 49.962

Review 3. Asia-Pacific clinical practice guidelines on the management of hepatocellular carcinoma: a 2017 update.

Authors: Masao Omata; Ann-Lii Cheng; Norihiro Kokudo; Masatoshi Kudo; Jeong Min Lee; Jidong Jia; Ryosuke Tateishi; Kwang-Hyub Han; Yoghesh K Chawla; Shuichiro Shiina; Wasim Jafri; Diana Alcantara Payawal; Takamasa Ohki; Sadahisa Ogasawara; Pei-Jer Chen; Cosmas Rinaldi A Lesmana; Laurentius A Lesmana; Rino A Gani; Shuntaro Obi; A Kadir Dokmeci; Shiv Kumar Sarin
Journal: Hepatol Int Date: 2017-06-15 Impact factor: 6.047

4. The impact of national viral hepatitis therapy program and hepatitis B vaccination program on mortality from acute and chronic viral hepatitis in Taiwan.

Authors: Shih-Yung Su
Journal: Hepatol Int Date: 2019-01-31 Impact factor: 6.047

Review 5. Liver diseases in the Asia-Pacific region: a Lancet Gastroenterology & Hepatology Commission.

Authors: Shiv K Sarin; Manoj Kumar; Mohammed Eslam; Jacob George; Mamun Al Mahtab; Sheikh M Fazle Akbar; Jidong Jia; Qiuju Tian; Rakesh Aggarwal; David H Muljono; Masao Omata; Yoshihiko Ooka; Kwang-Hyub Han; Hye Won Lee; Wasim Jafri; Amna S Butt; Chern H Chong; Seng G Lim; Raoh-Fang Pwu; Ding-Shinn Chen
Journal: Lancet Gastroenterol Hepatol Date: 2019-12-15

Review 6. Hepatocellular carcinoma mouse models: Hepatitis B virus-associated hepatocarcinogenesis and haploinsufficient tumor suppressor genes.

Authors: Yuan-Chi Teng; Zhao-Qing Shen; Cheng-Heng Kao; Ting-Fen Tsai
Journal: World J Gastroenterol Date: 2016-01-07 Impact factor: 5.742

Thirty-year outcomes of the national hepatitis B immunization program in Taiwan.

1. Cost-effectiveness of augmenting universal hepatitis B vaccination with immunoglobulin treatment: a case study in Zhejiang Province, East China.

2. Vaccines: taking a shot at protection.

Review 3. Asia-Pacific clinical practice guidelines on the management of hepatocellular carcinoma: a 2017 update.

4. The impact of national viral hepatitis therapy program and hepatitis B vaccination program on mortality from acute and chronic viral hepatitis in Taiwan.

Review 5. Liver diseases in the Asia-Pacific region: a Lancet Gastroenterology & Hepatology Commission.

Review 6. Hepatocellular carcinoma mouse models: Hepatitis B virus-associated hepatocarcinogenesis and haploinsufficient tumor suppressor genes.

Review 7. Insights From Antiviral Therapy Into Immune Responses to Hepatitis B and C Virus Infection.

Review 8. Cancer of childhood in sub-Saharan Africa.

Review 9. Molecular cancer prevention: Current status and future directions.

10. Transforming Cancer Prevention through Precision Medicine and Immune-oncology.